60891-70-5 Usage
Description
DIETHYL (5-NITROPYRIDIN-2-YL)MALONATE is a chemical compound with the molecular formula C13H13N3O7. This yellow crystalline solid is commonly used as a building block in the synthesis of pharmaceuticals and agrochemicals. It is classified as an ester, containing two ethyl groups and a malonate moiety linked to a 5-nitropyridine ring. DIETHYL (5-NITROPYRIDIN-2-YL)MALONATE is known for its reactivity in organic synthesis, particularly in the formation of heterocyclic compounds. It is important to handle this chemical with care, as it may pose health and environmental hazards.
Uses
Used in Pharmaceutical Industry:
DIETHYL (5-NITROPYRIDIN-2-YL)MALONATE is used as a building block for the synthesis of various pharmaceuticals. Its reactivity in organic synthesis allows for the formation of heterocyclic compounds, which are important in the development of new drugs.
Used in Agrochemical Industry:
DIETHYL (5-NITROPYRIDIN-2-YL)MALONATE is also used as a building block in the synthesis of agrochemicals. Its ability to form heterocyclic compounds makes it a valuable component in the development of new pesticides and other agricultural chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 60891-70-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,8,9 and 1 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 60891-70:
(7*6)+(6*0)+(5*8)+(4*9)+(3*1)+(2*7)+(1*0)=135
135 % 10 = 5
So 60891-70-5 is a valid CAS Registry Number.
60891-70-5Relevant articles and documents
As neuroprotective agents of pharmaceutical compounds
-
Paragraph 0299; 0300; 0301; 0302, (2019/06/26)
The invention discloses a medicinal compound as a neuroprotective agent. The medicinal compound is a neuronal nitric oxide synthase-postsynaptic density protein 95 (nNOS-PSD95) decoupling agent. The medicinal compound is a benzene ring derivative shown in the general formula (I) or its pharmaceutically acceptable salt. The invention further discloses a preparation method of the medicinal compound and a use of the medicinal compound in prevention and treatment on neuronal damage influence-caused diseases.
SUBSTITUTED HETEROAROMATIC PYRAZOLE-CONTAINING CARBOXAMIDE AND UREA DERIVATIVES AS VANILLOID RECEPTOR LIGANDS
-
Page/Page column 141, (2013/03/26)
The invention relates to substituted heteroaromatic pyrazole-containing carboxamide and urea derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
SUBSTITUTED HETEROCYCLIC AZA DERIVATIVES
-
Page/Page column 109, (2013/03/26)
The invention relates to heterocyclic aza derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.